Literature DB >> 30376043

Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study.

Scott P Kelly1, Hannah Lennon2, Matthew Sperrin3, Charles Matthews1, Neal D Freedman1, Demetrius Albanes1, Michael F Leitzmann4, Andrew G Renehan2,3, Michael B Cook1.   

Abstract

BACKGROUND: Previously we showed that adulthood body mass index (BMI) trajectories that result in obesity were associated with elevated risks of fatal prostate cancer (PCA). To further explore this relationship, we conducted a study within the NIH-AARP Diet and Health Study.
METHODS: Among 153 730 eligible men enrolled in the NIH-AARP cohort from 1995 to 1996 (median follow-up = 15.1 years), we identified 630 fatal PCA cases and 16 896 incident cases. BMI was assessed for ages 18, 35 and 50 and at study entry, enabling examination of latent class-identified BMI trajectories. Hazard ratios (HRs) and 95% confidence intervals (CI) were estimated using Cox proportional hazards regression.
RESULTS: BMI at study entry (mean age = 63, HR = 1.12; 95% CI = 1.01, 1.24, per 5-unit increase) and maximum BMI during adulthood (HR = 1.12; 95% CI = 1.02, 1.24, per 5-unit increase) shared modest associations with increased risk of fatal PCA. Smoking status likely modified the relationship between BMI trajectories and fatal PCA (Pinteraction = 0.035 via change-in-estimate variable section, P = 0.065 via full a priori model). Among never-smokers, BMI trajectory of normal weight to obesity was associated with increased risk of fatal disease (HR = 2.37; 95% CI = 1.38, 4.09), compared with the maintained normal weight trajectory, whereas there was no association among former or current-smokers. Total and non-aggressive PCA exhibited modest inverse associations with BMI at all ages, whereas no association was observed for aggressive PCA.
CONCLUSIONS: Increased BMI was positively associated with fatal PCA, especially among never-smokers. Future studies that examine PCA survival will provide additional insight as to whether these associations are the result of biology or confounding. Published by Oxford University Press on behalf of the International Epidemiological Association 2018. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  Body mass index; body weight; disease progression; fatal outcome; prostatic neoplasms; weight change

Mesh:

Year:  2019        PMID: 30376043      PMCID: PMC6469294          DOI: 10.1093/ije/dyy219

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  50 in total

Review 1.  Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.

Authors:  A Discacciati; N Orsini; A Wolk
Journal:  Ann Oncol       Date:  2012-01-06       Impact factor: 32.976

Review 2.  Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis.

Authors:  S Zhong; X Yan; Y Wu; X Zhang; L Chen; J Tang; J Zhao
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

3.  Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.

Authors:  Elisabeth Möller; Hans-Olov Adami; Lorelei A Mucci; Cecilia Lundholm; Rino Bellocco; Jan-Erik Johansson; Henrik Grönberg; Katarina Bälter
Journal:  Cancer Causes Control       Date:  2013-09-19       Impact factor: 2.506

4.  Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

Authors:  A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

5.  Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.

Authors:  Elisabeth Möller; Kathryn M Wilson; Julie L Batista; Lorelei A Mucci; Katarina Bälter; Edward Giovannucci
Journal:  Int J Cancer       Date:  2015-09-23       Impact factor: 7.396

6.  Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.

Authors:  Barbra A Dickerman; Thomas U Ahearn; Edward Giovannucci; Meir J Stampfer; Paul L Nguyen; Lorelei A Mucci; Kathryn M Wilson
Journal:  Int J Cancer       Date:  2017-06-08       Impact factor: 7.396

7.  Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.

Authors:  Scott P Kelly; Barry I Graubard; Gabriella Andreotti; Naji Younes; Sean D Cleary; Michael B Cook
Journal:  J Natl Cancer Inst       Date:  2016-10-20       Impact factor: 13.506

8.  Validity of self-reported height and weight in 4808 EPIC-Oxford participants.

Authors:  Elizabeth A Spencer; Paul N Appleby; Gwyneth K Davey; Timothy J Key
Journal:  Public Health Nutr       Date:  2002-08       Impact factor: 4.022

9.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants.

Authors:  Mariel M Finucane; Gretchen A Stevens; Melanie J Cowan; Goodarz Danaei; John K Lin; Christopher J Paciorek; Gitanjali M Singh; Hialy R Gutierrez; Yuan Lu; Adil N Bahalim; Farshad Farzadfar; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

10.  Accuracy of recalled body weight--a study with 20-years of follow-up.

Authors:  Anna K Dahl; Chandra A Reynolds
Journal:  Obesity (Silver Spring)       Date:  2013-06       Impact factor: 5.002

View more
  9 in total

1.  Do traditional BMI categories capture future obesity? A comparison with trajectories of BMI and incidence of cancer.

Authors:  Charlotte Watson; Dr Nophar Geifman
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

2.  Longitudinal trajectories of lifetime body shape and prostate cancer angiogenesis.

Authors:  Qiao-Li Wang; Mingyang Song; Steven K Clinton; Lorelei A Mucci; Jesper Lagergren; Edward L Giovannucci
Journal:  Eur J Epidemiol       Date:  2022-01-13       Impact factor: 8.082

3.  Menstrual cycle characteristics and incident cancer: a prospective cohort study.

Authors:  Siwen Wang; Yi-Xin Wang; Helena Sandoval-Insausti; Leslie V Farland; Jan L Shifren; Dan Zhang; JoAnn E Manson; Brenda M Birmann; Walter C Willett; Edward L Giovannucci; Stacey A Missmer; Jorge E Chavarro
Journal:  Hum Reprod       Date:  2022-01-28       Impact factor: 6.918

4.  Body mass index trajectories during mid to late life and risks of mortality and cardiovascular outcomes: Results from four prospective cohorts.

Authors:  Yun-Jiu Cheng; Zhen-Guang Chen; Su-Hua Wu; Wei-Yi Mei; Feng-Juan Yao; Ming Zhang; Dong-Ling Luo
Journal:  EClinicalMedicine       Date:  2021-03-18

5.  Overall and abdominal obesity and prostate cancer risk in a West African population: An analysis of the Ghana Prostate Study.

Authors:  Lauren M Hurwitz; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew A Adjei; James E Mensah; Evelyn Tay; Vicky Okyne; Ann Truelove; Scott P Kelly; Cindy Ke Zhou; Eboneé N Butler; Robert N Hoover; Ann W Hsing; Michael B Cook
Journal:  Int J Cancer       Date:  2020-05-06       Impact factor: 7.316

6.  Body Mass Index Trajectory-Specific Changes in Economic Circumstances: A Person-Oriented Approach Among Midlife and Ageing Finns.

Authors:  Jatta Salmela; Tea Lallukka; Elina Mauramo; Ossi Rahkonen; Noora Kanerva
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

7.  Distinct developmental trajectories of body mass index and diabetes risk: A 5-year longitudinal study of Chinese adults.

Authors:  Haijiang Dai; Fei Li; Nicola Luigi Bragazzi; Jiangang Wang; Zhiheng Chen; Hong Yuan; Yao Lu
Journal:  J Diabetes Investig       Date:  2019-09-21       Impact factor: 4.232

8.  Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.

Authors:  Céline Lavalette; Emilie Cordina Duverger; Fanny Artaud; Xavier Rébillard; Pierre-Jean Lamy; Brigitte Trétarre; Sylvie Cénée; Florence Menegaux
Journal:  Cancer Med       Date:  2020-07-08       Impact factor: 4.452

9.  Determinants and extent of weight recording in UK primary care: an analysis of 5 million adults' electronic health records from 2000 to 2017.

Authors:  B D Nicholson; P Aveyard; C R Bankhead; W Hamilton; F D R Hobbs; S Lay-Flurrie
Journal:  BMC Med       Date:  2019-11-29       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.